About IGF-1 DES
IGF-1 DES is a truncated IGF-1 variant lacking the first three amino acids, used in research investigating IGF-1 receptor signaling and localized pathway dynamics. Supplied as a lyophilized powder for laboratory studies of growth-factor signaling kinetics in controlled experimental models. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-97 (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality.
Recent research on IGF-1 DES: Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality.
Read Full Study on PubMedNovel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model.
Recent research on IGF-1 DES: Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model.
Read Full Study on PubMedAdditional Studies
Normative data for insulin-like growth factor-1 and insulin-like growth factor binding protein-3 and their determinants in healthy adult males from india: the INDIIGo study.
Recent research on IGF-1 DES: Normative data for insulin-like growth factor-1 and insulin-like growth factor binding protein-3 and their determinants in healthy adult males from india: the INDIIGo study.
Read on PubMedLoss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5).
Recent research on IGF-1 DES: Loss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5).
Read on PubMedNAD(+) repletion restores cardioprotective autophagy and mitophagy in obesity-associated heart failure by suppressing excessive trophic signaling.
Recent research on IGF-1 DES: NAD(+) repletion restores cardioprotective autophagy and mitophagy in obesity-associated heart failure by suppressing excessive trophic signaling.
Read on PubMedCardiomyopathy in Patients With Acromegaly - Not Truly a Concern Anymore?
Recent research on IGF-1 DES: Cardiomyopathy in Patients With Acromegaly - Not Truly a Concern Anymore?
Read on PubMedCost-utility analysis of second line acromegaly treatment in France.
Recent research on IGF-1 DES: Cost-utility analysis of second line acromegaly treatment in France.
Read on PubMedExploring the Therapeutic Potential of Bovine Colostrum for Cancer Therapies.
Recent research on IGF-1 DES: Exploring the Therapeutic Potential of Bovine Colostrum for Cancer Therapies.
Read on PubMedRelated Research
Purchase IGF-1 DES from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.